View Older Stories View More Recent Stories

Apr 5, 2022 08:25AM Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
Apr 5, 2022 08:16AM Agilent (A) Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
Apr 5, 2022 08:15AM Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
Apr 4, 2022 08:00AM Agilent Joins AMBIC to Advance Biomanufacturing
Mar 15, 2022 07:10AM Arima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational Applications
Mar 10, 2022 08:00AM Agilent Announces the 2022 Darlene Solomon Award Presented to Grenoble Alpes University Hospital Scientist Dr. Federica Fiorini
Mar 3, 2022 12:15PM Edwards Invests in New Arizona Facility to Support North America Semiconductor Growth
Feb 24, 2022 01:52PM Agilent to Participate at Cowen and Barclays Health Care Conferences
Feb 24, 2022 08:00AM Agilent and University of Vermont Announce the Agilent Laboratory for Chemical Analysis (ALCA)
Feb 23, 2022 08:00AM Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening
Feb 22, 2022 04:05PM Agilent Reports First-Quarter Fiscal Year 2022 Financial Results
Feb 17, 2022 09:01AM Agilent Technologies (A) Acquires Artificial Intelligence Technology
Feb 17, 2022 09:00AM Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity
Feb 15, 2022 04:05PM Agilent Announces Cash Dividend of 21 Cents per Share
Feb 4, 2022 08:00AM Agilent Highlights Integrated Automation Solutions at SLAS 2022
Jan 26, 2022 08:00PM Agilent and A*STAR’s SIFBI Sign Research Collaboration Agreement to Advance Singapore Agri-Food Industry
Jan 24, 2022 08:30AM Agilent Announces the Innovative Seahorse XF Pro Analyzer
Jan 13, 2022 04:05PM Agilent to Webcast First-Quarter Fiscal Year 2022 Financial Results Presentation
Jan 10, 2022 08:18AM Agilent Presents Thought Leader Award to Professor Jason Kovacic
Dec 16, 2021 09:41AM Nicoya Extends Series A Financing With Additional $20m to Meet Demand of Rapidly Growing Proteomics Industry
Dec 14, 2021 11:00AM Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
Dec 6, 2021 08:00AM Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
Nov 23, 2021 03:00PM Agilent to Present at Evercore ISI Virtual Healthcare Conference
Nov 22, 2021 04:05PM Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results
Nov 18, 2021 04:09PM Agilent Technologies (A) Appoints Otis Brawley to its Board
Nov 18, 2021 04:05PM Dr. Otis Brawley Named to Agilent Board of Directors
Nov 17, 2021 04:05PM Agilent Increases Cash Dividend to 21 Cents Per Share
Nov 2, 2021 02:00PM Agilent Names John Palma to Lead Global Medical Affairs Organization
Nov 1, 2021 08:06AM Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
Oct 28, 2021 04:48PM Agilent Technologies (A) Expands PD-L1 Label to Include Triple-Negative Breast Cancer in the EU
Oct 28, 2021 04:47PM Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
Oct 28, 2021 04:05PM Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
Oct 27, 2021 08:00AM Agilent Commits to Net-Zero Greenhouse Gas Emissions by 2050
Oct 26, 2021 08:05AM Agilent Announced as My Green Lab's First 'Transformative Level' Sponsor and First Sponsor of the My Green Lab Certification Program
Oct 21, 2021 08:36AM Agilent (A) PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Oct 21, 2021 08:31AM Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Oct 13, 2021 04:16PM Agilent Technologies (A) Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
Oct 13, 2021 04:16PM Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
Sep 28, 2021 08:00AM Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)
Sep 23, 2021 04:06PM Agilent Technologies (A) Appoints Mikael Dolsten Named to its Board
Sep 23, 2021 04:05PM Dr. Mikael Dolsten Named to Agilent Board of Directors
Sep 22, 2021 04:05PM Agilent Announces Cash Dividend of 19.4 Cents per Share
Sep 7, 2021 08:00AM Agilent Announces Thought Leader Award to David R. Liu at the Broad Institute
Sep 2, 2021 08:00AM Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement
Sep 1, 2021 11:00AM Agilent to Present at Wells Fargo Virtual Healthcare Conference
Aug 23, 2021 11:00AM Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer
Aug 19, 2021 08:00AM Researchers Develop COVID-19 Severity Screening Method Based on the Agilent Cary 630 FTIR Spectrometer
Aug 17, 2021 04:05PM Agilent Reports Third-Quarter Fiscal Year 2021 Financial Results
Aug 4, 2021 11:00AM Agilent Earns 2021 Great Place to Work Certification in the U.S.
Aug 3, 2021 08:20AM Agilent Announces Target Enrichment Manufacturing Facility in China
View More Recent Stories View Older Stories